Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Downregulation of DNA methyltransferase-3a ameliorates the osteogenic differentiation ability of adipose-derived stem cells in diabetic osteoporosis via Wnt/β-catenin signaling pathway

Fig. 2

Decrease of the osteogenic differentiation capacity in DOP-ASCs. A: Alizarin Red-S staining of control ASCs and DOP-ASCs. B: mRNA levels of osteogenesis-related molecules Runx2 and Opn after 3 and 7 days of osteoinduction. C: Immunofluorescence staining of RUX2 and OPN proteins in control ASCs and DOP-ASCs after 4 days of osteoinduction. D: Protein levels of osteogenesis-related molecules RUNX2 and OPN after 3 and 7 days of osteoinduction. Data represent the mean ± SD of at least three independent experiments, *P < 0.05, **P < 0.01

Back to article page